Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 10/20 | 0.82 |
| ▸ | IAPP | P10997 | 5/20 | 0.72 |
| ▸ | TOP2A | P11388 | 3/20 | 0.54 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9363841 | 1.00 | APP (0.82) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL9363805 | 1.00 | APP (0.82) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL9363801 | 1.00 | APP (0.82) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL9363836 | 1.00 | APP (0.82) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL9364085 | 0.99 | APP (0.80) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL9364078 | 0.99 | APP (0.80) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL19369293 | 0.90 | APP (1.00) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL10825839 | 0.90 | APP (1.00) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL10826170 | 0.90 | APP (1.00) | APPIAPPTOP2AHTR1ATTR | |
| SCHEMBL21133739 | 0.90 | APP (1.00) | APPIAPPTOP2AHTR1ATTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114748518-B | Oral preparation containing caffeic acid ester and breviscapine for treating intestinal cancer, and its preparation method | 云南生物谷药业股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-114748518-A | Oral preparation containing caffeic acid ester and breviscapine and preparation method thereof | 云南生物谷药业股份有限公司 | 2022-07-15 | — | — | CN | disclosed |